Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.

Choudhury NJ; Campanile A; Antic T; Yap KL; Fitzpatrick CA; Wade JL 3rd; Karrison T; Stadler WM; Nakamura Y; O'Donnell PH

doi:10.1200/jco.2015.66.3047

Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.

Identifier:nobleid.org/w1/20260526/8B6DFBC7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8B6DFBC7.svg?ark=w1%2F20260526%2F8B6DFBC7)](https://nobleid.org/work/w1/20260526/8B6DFBC7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.

Identifier:nobleid.org/w1/20260526/8B6DFBC7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8B6DFBC7.svg?ark=w1%2F20260526%2F8B6DFBC7)](https://nobleid.org/work/w1/20260526/8B6DFBC7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work